Susquehanna International Group’s Cellebrite CLBT Stock Holding History
Bought
Maintained
Sold
Other funds holding CLBT
TWCM
VC
PP
PF
NTCM
CI
Susquehanna International Group's CLBT Position: Q1 2026 in Review
Susquehanna International Group increased its Cellebrite (CLBT) stake by 27% in Q1 2026, buying an estimated $326K and bringing the position to 101,616 shares worth $1.4M. The position accounts for ﹤0.01% of the portfolio, ranked #7066.
Susquehanna International Group first reported a position in CLBT in Q4 2021 and has held it in 16 quarters since. The position peaked at $5.13M in Q3 2025. 220 funds tracked by Wall St. Rank hold CLBT as of Q1 2026.
- Susquehanna International Group held 101,616 shares of Cellebrite worth $1.4M as of Q1 2026.
- Susquehanna International Group bought 21,632 Cellebrite shares in Q1 2026, an estimated $326K.
- Cellebrite made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #7066 holding.
- Susquehanna International Group first reported a position in Cellebrite in Q4 2021 and has held it in 16 quarters since.
- Susquehanna International Group's Cellebrite position peaked at $5.13M in Q3 2025.
- 220 funds tracked by Wall St. Rank held Cellebrite as of Q1 2026.
Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.